Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Tsart-M 40/25 Tablet ER

Prescription Icon
Prescription Required

Marketer

Alkem Laboratories Ltd

Salt Composition

Telmisartan (40mg) + Metoprolol Succinate (25mg)

Overview Tsart-M 40/25 Tablet ER

Cardiovasc-40/25 Extended-Release tablets manage hypertension, reducing the risk of strokes and heart attacks. Prompt treatment improves heart attack survival rates. Consistent blood levels are achieved by taking this medication with food at the same time daily, as directed by your physician; don't discontinue it independently, even feeling well, as hypertension is often asymptomatic. Lifestyle modifications – regular exercise, weight management, and a balanced diet – complement this treatment. Adhere strictly to your doctor's instructions. Potential side effects include headache, fatigue, dizziness, low blood pressure, elevated potassium, orthostatic hypotension (possibly with fainting), shortness of breath, nausea, vomiting, and stomach pain. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly from a seated position. Regular monitoring of blood pressure, blood sugar, kidney function, urea, and electrolytes may be necessary. Inform your doctor of any kidney or liver issues before starting this medication. Pregnant or lactating individuals should consult their physician before use. Always disclose all medications, especially those for hypertension or cardiac conditions.

Uses of Tsart-M 40/25 Tablet ER

Managing Elevated Blood Pressure

Major Benefits of Tsart-M 40/25 Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Tsart-M 40/25 Extended-Release Tablet should be administered with food.

Common Side effects of Tsart-M 40/25 Tablet ER:

  • Headache
  • Weakness
  • Dizziness
  • Cold extremities
  • Slow heart rate
  • Increased potassium level in blood
  • Decreased blood pressure
  • Orthostatic hypotension (sudden lowering of blood pressure on standing)
  • Breathlessness
  • Vomiting
  • Abdominal pain

How to use Tsart-M 40/25 Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Tsart-M 40/25 Tablet ER with a meal.

How Tsart-M 40/25 Tablet ER works:

Telmisartan and Metoprolol Succinate, combined in Tsart-M 40/25 ER tablets, provide dual blood pressure control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Tsart-M 40/25 Tablet ER is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Tsart-M 40/25 tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Tsart-M 40/25 tablets are likely safe for breastfeeding mothers. Available human data indicates minimal infant risk associated with the medication.

DrivingDrivingUNSAFE

Extended-release Tsart-M 40/25 tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

The extended-release Tsart-M 40/25 Tablet is considered safe for individuals with impaired renal function. No alteration of the Tsart-M 40/25 Tablet ER dosage is necessary.

LiverLiverCAUTION

Patients with liver impairment should use Tsart-M 40/25 Extended-Release tablets cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Tsart-M 40/25 Tablet ER :

Should you forget to take a Tsart-M 40/25 Tablet ER, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Tsart-M 40/25 Tablet ER

LabelValue
Addictive None.
Treatment Category Heart-related

FAQs on Tsart-M 40/25 Tablet ER

Dizziness is a possible side effect of Tsart-M 40/25 Tablet ER Succinate. This side effect may be experienced upon standing after prolonged periods of sitting or lying down. To mitigate this risk, stand up gradually after lying down or sitting.
Adopting a healthier lifestyle complements the effects of Tsart-M 40/25 Tablet ER Succinate. Smoking cessation is crucial, as it significantly raises the risk of cardiovascular events. Weight management is important for those who are overweight or obese. A balanced diet rich in fruits and vegetables is recommended. Regular physical activity strengthens the heart and lowers the likelihood of a heart attack.
Continue taking your prescribed Tsart-M 40/25 Tablet ER as directed, even if you are feeling healthy. Abruptly discontinuing Tsart-M 40/25 Tablet ER can result in severe adverse events, including myocardial infarction and cerebrovascular accident.
Store the medication in its original, tightly sealed container. Follow the storage instructions provided on the packaging. Discard any leftover medication and ensure it remains inaccessible to children, pets, and others.
Tsart-M 40/25 Tablet ER
152
MRP 186
18% off